These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7346284)

  • 21. Focal nodular hyperplasia of the liver and contraceptive steroids.
    St Omer FB; Iozzo RV; Casetti P; Dellarolle AC
    Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):319-21. PubMed ID: 696209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Estrogen-induced porphyria cutanea tarda, 2 cases].
    Wanscher B
    Ugeskr Laeger; 1975 Mar; 137(11):623-5. PubMed ID: 1145774
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hepatic changes caused by contraceptive steroids].
    Uribe M; de Uribe MH; Carío AA
    Rev Gastroenterol Mex; 1977; 42(3):139-47. PubMed ID: 616980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Porphyria cutanea tarda and the pill: case report.
    Austad WI; Hamilton-Gibbs JS
    N Z Med J; 1975 Jan; 81(531):8-10. PubMed ID: 1055316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Spontaneous subcapsular hepatic hematoma].
    Guerrero Jiménez P; Canis López M; Rodríquez Vives A; Miño Fugarolas G; Pera Madrazo C
    Rev Esp Enferm Apar Dig; 1982 Aug; 62(2):135-8. PubMed ID: 7146560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients.
    Grossman ME; Bickers DR; Poh-Fitzpatrick MB; Deleo VA; Harber LC
    Am J Med; 1979 Aug; 67(2):277-86. PubMed ID: 463934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Systemic changes during the use of hormonal contraceptives].
    Manuilova IA; Trutko NS; Dubnitskaia LV; Kuramshina AKh
    Akush Ginekol (Mosk); 1983 Nov; (11):14-7. PubMed ID: 6666789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of porphyria cutanea tarda after oral contraceptive therapy. Case report].
    Vosmík F; Kordac V
    Cesk Dermatol; 1974 Oct; 49(5):298-303. PubMed ID: 4429985
    [No Abstract]   [Full Text] [Related]  

  • 29. [Benign hepatomata while taking oral contraceptives (author's transl)].
    Düsel W; Böttger G; Kolokythas A; Romen W
    MMW Munch Med Wochenschr; 1980 May; 122(19):693-6. PubMed ID: 6771573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Liver cell carcinoma associated with oral contraceptives (author's transl)].
    Leclère J; Meot B; Marchal F; Mizrahi R; Collard F; Rauber G; Hartemann P
    Ann Endocrinol (Paris); 1977; 38(6):361-2. PubMed ID: 206178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Incidence of toxic liver lesions due to Gravistat].
    Link H; Metzner C; Ziesenhenn K
    Z Gesamte Inn Med; 1978 Mar; 33(6):187-9. PubMed ID: 645155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Porphyria cutanea tarda caused by long-term use of femigen].
    Chowaniec O; Wierzbieta J
    Przegl Dermatol; 1980; 67(3):349-52. PubMed ID: 6159665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porphyria cutanea tarda complicating Wilson's disease.
    Chesney TM; Wardlaw LL; Kaplan RJ; Chow JF
    J Am Acad Dermatol; 1981 Jan; 4(1):64-6. PubMed ID: 7204691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quantitative liver function tests in porphyria cutanea tarda: improvement under therapeutic phlebotomy].
    Meister F; Reichen J
    Schweiz Med Wochenschr; 1986 Mar; 116(11):341-5. PubMed ID: 3961453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Internal medicine problems regarding contraception. Part I].
    Mall-Haefeli M
    Schweiz Med Wochenschr; 1980 Sep; 110(36):1314-9. PubMed ID: 7444416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Behaviour of ujoviridin exposure test (ICG) in conjunction with application of hormonal contraceptives (author's transl)].
    Brügmann E; Göretzlehner G
    Zentralbl Gynakol; 1981; 103(14):823-6. PubMed ID: 7293553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic and pathogenetic aspects of porphyria cutanea tarda].
    Köstler E; Seebacher C; Riedel H; Kemmer C
    Hautarzt; 1986 Apr; 37(4):210-6. PubMed ID: 3009356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rifampicin-induced porphyria cutanea tarda.
    Millar JW
    Br J Dis Chest; 1980 Oct; 74(4):405-8. PubMed ID: 6452153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral contraceptives causing porphyria cutanea tarda].
    Ruszczak Z; Przyk K; Prószyńska-Kuczyńska W
    Wiad Lek; 1973 Dec; 26(23):2177-80. PubMed ID: 4588417
    [No Abstract]   [Full Text] [Related]  

  • 40. [Oncological aspects of hormonal contraception].
    Bokhman IaV; Korkhov VV; Safronnikova NR
    Akush Ginekol (Mosk); 1981 Apr; (4):3-5. PubMed ID: 7018284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.